ALNY logo

Alnylam Pharmaceuticals (ALNY) Current assets

annual current assets:

$3.30B+$312.59M(+10.48%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual total current assets is $3.30 billion, with the most recent change of +$312.59 million (+10.48%) on December 31, 2024.
  • During the last 3 years, ALNY annual current assets has risen by +$486.71 million (+17.33%).
  • ALNY annual current assets is now at all-time high.

Performance

ALNY Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly current assets:

$3.27B-$27.03M(-0.82%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly total current assets is $3.27 billion, with the most recent change of -$27.03 million (-0.82%) on March 31, 2025.
  • Over the past year, ALNY quarterly current assets has increased by +$279.65 million (+9.36%).
  • ALNY quarterly current assets is now -2.60% below its all-time high of $3.36 billion, reached on September 30, 2024.

Performance

ALNY quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

ALNY Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.5%+9.4%
3 y3 years+17.3%+26.2%
5 y5 years+92.0%+106.2%

ALNY Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+22.4%-2.6%+32.2%
5 y5-yearat high+92.0%-2.6%+106.2%
alltimeall timeat high>+9999.0%-2.6%>+9999.0%

ALNY Current assets History

DateAnnualQuarterly
Mar 2025
-
$3.27B(-0.8%)
Dec 2024
$944.70M(+11.5%)
$3.30B(-1.8%)
Sep 2024
-
$3.36B(+5.8%)
Jun 2024
-
$3.17B(+6.2%)
Mar 2024
-
$2.99B(+0.2%)
Dec 2023
$847.18M(-0.8%)
$2.98B(-0.1%)
Sep 2023
-
$2.99B(+18.3%)
Jun 2023
-
$2.52B(-0.7%)
Mar 2023
-
$2.54B(-5.6%)
Dec 2022
$854.11M(+2.3%)
$2.69B(+0.1%)
Sep 2022
-
$2.69B(+8.9%)
Jun 2022
-
$2.47B(-4.6%)
Mar 2022
-
$2.59B(-7.8%)
Dec 2021
$834.73M(+5.4%)
$2.81B(+5.0%)
Sep 2021
-
$2.68B(-1.8%)
Jun 2021
-
$2.73B(+38.3%)
Mar 2021
-
$1.97B(-24.7%)
Dec 2020
$792.28M(+16.6%)
$2.61B(+27.3%)
Sep 2020
-
$2.05B(-4.9%)
Jun 2020
-
$2.16B(+36.3%)
Mar 2020
-
$1.58B(-7.6%)
Dec 2019
$679.27M(+81.6%)
$1.72B(-9.6%)
Sep 2019
-
$1.90B(-8.1%)
Jun 2019
-
$2.06B(+48.3%)
Mar 2019
-
$1.39B(+15.9%)
Dec 2018
$374.11M(+62.7%)
$1.20B(-10.5%)
Sep 2018
-
$1.34B(-10.7%)
Jun 2018
-
$1.50B(-10.8%)
Mar 2018
-
$1.69B(-4.5%)
Dec 2017
$229.99M(-61.1%)
$1.76B(+77.7%)
Sep 2017
-
$993.37M(+3.4%)
Jun 2017
-
$960.71M(+60.9%)
Mar 2017
-
$597.19M(-11.1%)
Dec 2016
$590.93M(+110.2%)
$671.88M(-10.1%)
Sep 2016
-
$747.56M(-15.8%)
Jun 2016
-
$888.07M(-15.4%)
Mar 2016
-
$1.05B(-5.0%)
Dec 2015
$281.12M(-15.6%)
$1.11B(+6.1%)
Sep 2015
-
$1.04B(+1.2%)
Jun 2015
-
$1.03B(-5.6%)
Mar 2015
-
$1.09B(+46.1%)
Dec 2014
$333.23M
$746.37M(+16.1%)
Sep 2014
-
$643.02M(-3.3%)
DateAnnualQuarterly
Jun 2014
-
$665.12M(-1.3%)
Mar 2014
-
$674.06M(+165.3%)
Dec 2013
$166.50M(+2.8%)
$254.03M(+27.5%)
Sep 2013
-
$199.16M(-7.1%)
Jun 2013
-
$214.36M(-10.7%)
Mar 2013
-
$240.11M(+91.2%)
Dec 2012
$161.96M(+24.7%)
$125.56M(-46.8%)
Sep 2012
-
$235.93M(-1.8%)
Jun 2012
-
$240.34M(+15.3%)
Mar 2012
-
$208.54M(+37.2%)
Dec 2011
$129.89M(-6.6%)
$152.03M(-15.5%)
Sep 2011
-
$179.96M(-19.8%)
Jun 2011
-
$224.33M(-10.5%)
Mar 2011
-
$250.71M(-1.3%)
Dec 2010
$139.13M(-25.9%)
$254.14M(+3.9%)
Sep 2010
-
$244.62M(-10.6%)
Jun 2010
-
$273.51M(+0.1%)
Mar 2010
-
$273.31M(-6.9%)
Dec 2009
$187.85M(+68.4%)
$293.53M(+28.6%)
Sep 2009
-
$228.16M(-18.1%)
Jun 2009
-
$278.42M(-33.6%)
Mar 2009
-
$419.34M(-5.4%)
Dec 2008
$111.55M(+16.3%)
$443.12M(-1.9%)
Sep 2008
-
$451.78M(-18.0%)
Jun 2008
-
$550.63M(+20.9%)
Mar 2008
-
$455.48M(+14.5%)
Dec 2007
$95.89M(+456.8%)
$397.90M(-16.7%)
Sep 2007
-
$477.63M(+136.5%)
Jun 2007
-
$201.96M(-3.8%)
Mar 2007
-
$209.92M(-5.8%)
Dec 2006
$17.22M(+8.1%)
$222.78M(+75.7%)
Sep 2006
-
$126.83M(-1.7%)
Jun 2006
-
$129.06M(-5.9%)
Mar 2006
-
$137.12M(+66.4%)
Dec 2005
$15.93M(-11.1%)
$82.41M(+208.7%)
Sep 2005
-
$26.70M(-21.1%)
Jun 2005
-
$33.84M(-18.3%)
Mar 2005
-
$41.44M(-14.0%)
Dec 2004
$17.93M(+63.1%)
$48.18M(+2.1%)
Sep 2004
-
$47.20M(-6.6%)
Jun 2004
-
$50.51M(+123.6%)
Mar 2004
-
$22.59M(-6.6%)
Dec 2003
$10.99M(+1757.1%)
$24.19M
Dec 2002
$592.00K
-

FAQ

  • What is Alnylam Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual current assets year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly current assets year-on-year change?

What is Alnylam Pharmaceuticals annual total current assets?

The current annual current assets of ALNY is $3.30B

What is the all time high annual current assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual total current assets is $3.30B

What is Alnylam Pharmaceuticals annual current assets year-on-year change?

Over the past year, ALNY annual total current assets has changed by +$312.59M (+10.48%)

What is Alnylam Pharmaceuticals quarterly total current assets?

The current quarterly current assets of ALNY is $3.27B

What is the all time high quarterly current assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly total current assets is $3.36B

What is Alnylam Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, ALNY quarterly total current assets has changed by +$279.65M (+9.36%)
On this page